SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125 | 0.0% | 4,148 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $125 | -24.7% | 4,148 | -9.7% | 0.00% | 0.0% |
| Q1 2023 | $166 | +6.4% | 4,594 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $156 | -99.9% | 4,594 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $156,000 | +17.3% | 4,594 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $133,000 | -58.7% | 4,594 | -66.2% | 0.00% | -50.0% |
| Q4 2019 | $322,000 | -13.9% | 13,592 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $374,000 | -49.8% | 13,592 | -39.6% | 0.00% | -50.0% |
| Q2 2019 | $745,000 | -5.6% | 22,509 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $789,000 | +68.2% | 22,509 | +141.9% | 0.01% | +50.0% |
| Q3 2018 | $469,000 | -15.8% | 9,306 | 0.0% | 0.00% | -20.0% |
| Q2 2018 | $557,000 | -57.1% | 9,306 | -67.2% | 0.01% | -58.3% |
| Q1 2018 | $1,299,000 | +15.0% | 28,358 | 0.0% | 0.01% | +20.0% |
| Q4 2017 | $1,130,000 | -0.4% | 28,358 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $1,134,000 | -7.2% | 28,358 | 0.0% | 0.01% | -16.7% |
| Q2 2017 | $1,222,000 | – | 28,358 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |